Costs and persistence of carbonic anhydrase inhibitor versus alpha-2 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK-GPRD database

Author： Lafuma A.   Berdeaux G.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.24, Iss.5, 2008-05, pp. : 1519-1527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Cyclooxygenase-2 Inhibitor Celecoxib Is a Potent Inhibitor of Human Carbonic Anhydrase II

By Knudsen James   Carlsson Uno   Hammarström Per   Sokol Gerald   Cantilena Louis  

Inflammation, Vol. 28, Iss. 5, 2004-10 ,pp. : 285-290

Springer Publishing Company

Access to resources Recommend Favorite

Costs and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: analysis conducted on the United Kingdom General Practitioner Research Database

By Lafuma A   Berdeaux G.  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3009-3016

Informa Healthcare

Access to resources Recommend Favorite

Agonistic β2 receptor autoantibodies in ocular hypertension and open‐angle glaucoma

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

THE USE OF A CARBONIC ANHYDRASE INHIBITOR IN THE TREATMENT OF HYPERKALEMIA†

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 4, Iss. 1, 1956-01 ,pp. : 58-64

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial*

By Cantor† Louis B.   Safyan Eleonora   Liu Ching-Chi   Batoosingh Amy L.  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 2035-2043

Informa Healthcare

Access to resources Recommend Favorite